Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial

Heather Platt, Tosin Omole, José F. Cardona, Neil J. Fraser, Richard A. Mularski, Charles M. Andrews, Nizar Daboul, Nancy Gallagher, Aditi Sapre, Jianing Li, Adam B. Polis, Doreen Fernsler, Gretchen Tamms, Weifeng Xu, Rocio Murphy, Julie M. Skinner, Joseph G. Joyce, Luwy Musey